107 related articles for article (PubMed ID: 6167049)
1. Urinary cholesterol in follow-up of patients with urologic carcinomas or benign prostatic hyperplasia.
Jüngst D; Tauber R; Lazik E; Karl HJ
Urology; 1981 Jul; 18(1):65-7. PubMed ID: 6167049
[TBL] [Abstract][Full Text] [Related]
2. Studies on the clinical significance of nonesterified and total cholesterol in urine.
Jüngst D; Wallner J; Pickel A; Stadler A; Eiermann W; Marx FJ; Karl HJ
Klin Wochenschr; 1981 Jun; 59(11):545-52. PubMed ID: 6167760
[TBL] [Abstract][Full Text] [Related]
3. [Cholesterol and urinary tract diseases].
Frick J; Spiteller G
Z Urol Nephrol; 1968 Dec; 61(12):833-8. PubMed ID: 4183283
[No Abstract] [Full Text] [Related]
4. [Urinary excretion of cholesterol in various diseases. (Especially in cancer of the urogenital system)].
Spiteller-Friedmann M; Spiteller G; Spiteller H; Frick J
Osterr Z Erforsch Bekampf Krebskr; 1971; 26(1):25-35. PubMed ID: 5171242
[No Abstract] [Full Text] [Related]
5. Urinary cholesterol excretion in men with benign prostatic hyperplasia and carcinoma of the prostate.
Juengst D; Pickel A; Elsaesser E; Marx FJ; Karl HJ
Cancer; 1979 Jan; 43(1):353-9. PubMed ID: 83906
[No Abstract] [Full Text] [Related]
6. [Clinical significance of cholesterol excretion in the urine].
Jüngst D; Osterholzer M; Lazik E; Karl HJ
Acta Med Austriaca Suppl; 1979; 6():406-9. PubMed ID: 299242
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of nuclear matrix protein-22 as a clinical diagnostic marker for bladder cancer.
Chang YH; Wu CH; Lee YL; Huang PH; Kao YL; Shiau MY
Urology; 2004 Oct; 64(4):687-92. PubMed ID: 15491702
[TBL] [Abstract][Full Text] [Related]
8. [Detection of urinary polyamine by a new enzymatic differential assay. (III). Studies on urinary polyamines in patients with malignant genitourinary diseases].
Sakai S; Ito Y; Koide T; Tei K; Hara A; Sawada H
Hinyokika Kiyo; 1986 Mar; 32(3):343-50. PubMed ID: 2425608
[TBL] [Abstract][Full Text] [Related]
9. Significance of urinary neopterin in patients with malignant tumors of the genitourinary tract.
Aulitzky W; Frick J; Fuchs D; Hausen A; Reibnegger G; Wachter H
Cancer; 1985 Mar; 55(5):1052-5. PubMed ID: 3967190
[TBL] [Abstract][Full Text] [Related]
10. Urinary cholesterol in cancer screening.
Jüngst D; Osterholzer M; Tauber R; Karl HJ
Urology; 1982 Nov; 20(5):495-8. PubMed ID: 7147529
[TBL] [Abstract][Full Text] [Related]
11. [Excretion of urinary hydroxyproline in urinary tract diseases].
Guarino A; Comar OB; Taccone W; Cicalese V
Arch Sci Med (Torino); 1979; 136(2):249-54. PubMed ID: 92978
[TBL] [Abstract][Full Text] [Related]
12. Urinary cholesterol. V. Its excretion in men with testicular and prostatic neoplasms.
Acevedo HF; Campbell EA; Saier EL; Frich JC; Merkow LP; Hayeslip DW; Bartok SP; Grauer RC; Hamilton JL
Cancer; 1973 Jul; 32(1):196-205. PubMed ID: 4123791
[No Abstract] [Full Text] [Related]
13. Carcinoma of urinary tract. Clinical significance of urinary phosphokinase activity in diagnosis.
Block NL; Jaksy J; Tessler AN
Urology; 1974 Aug; 4(2):174-81. PubMed ID: 4850881
[No Abstract] [Full Text] [Related]
14. Urinary basic fibroblast growth factor in patients with bladder cancer and benign prostatic hypertrophy.
O'Brien TS; Smith K; Cranston D; Fuggle S; Bicknell R; Harris AL
Br J Urol; 1995 Sep; 76(3):311-4. PubMed ID: 7551838
[TBL] [Abstract][Full Text] [Related]
15. The clinical significance of increased activity of urinary lactic dehydrogenase.
Kiser WS; Riggins RS
J Urol; 1966 Oct; 96(4):559-64. PubMed ID: 4162696
[No Abstract] [Full Text] [Related]
16. Preliminary evaluation of urinary polyamines in the diagnosis of genitourinary tract malignancy.
Sanford EJ; Drago JR; Rohner TJ; Kessler GF; Sheehan L; Lipton A
J Urol; 1975 Feb; 113(2):218-21. PubMed ID: 1113419
[TBL] [Abstract][Full Text] [Related]
17. Urinary tissue factor levels in patients with bladder and prostate cancer.
Lwaleed BA; Francis JL; Chisholm M
Eur J Surg Oncol; 2000 Feb; 26(1):44-9. PubMed ID: 10718179
[TBL] [Abstract][Full Text] [Related]
18. The CEA test in urologic cancer: an evaluation and a review.
Guinan P; Dubin A; Bush I; Alsheik H; Ablin RJ
Oncology; 1975; 32(3-4):158-68. PubMed ID: 1241122
[TBL] [Abstract][Full Text] [Related]
19. Detection of bladder tumor by urine cytology in cases of prostatic hypertrophy.
Rammou-Kinia R; Anagnostopoulou I
Diagn Cytopathol; 1996 Dec; 15(5):409-11. PubMed ID: 8989544
[TBL] [Abstract][Full Text] [Related]
20. Human chorionic gonadotropin detected in urinary concentrates from patients with malignant tumors of the testis, prostate, bladder, ureter and kidney.
Fukutani K; Libby JM; Panko WB; Scardino PT
J Urol; 1983 Jan; 129(1):74-7. PubMed ID: 6827688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
